N-(4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)phenyl)acrylamide

ID: ALA4746272

PubChem CID: 162648400

Max Phase: Preclinical

Molecular Formula: C23H23N5O2

Molecular Weight: 401.47

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1

Standard InChI:  InChI=1S/C23H23N5O2/c1-2-22(29)25-18-5-3-17(4-6-18)21-11-12-24-23(27-21)26-19-7-9-20(10-8-19)28-13-15-30-16-14-28/h2-12H,1,13-16H2,(H,25,29)(H,24,26,27)

Standard InChI Key:  UXJWKEBWYYWGQW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   21.7573  -13.5620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7562  -14.3816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4642  -14.7905    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.1739  -14.3811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1711  -13.5584    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.4624  -13.1532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4572  -12.3388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1653  -11.9287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1632  -11.1123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4538  -10.7050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7449  -11.1201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7505  -11.9352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8822  -14.7886    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.5893  -14.3789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4502   -9.8878    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.1562   -9.4762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1526   -8.6590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8656   -9.8817    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.8586   -8.2473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2943  -14.7868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0009  -14.3778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0001  -13.5597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2868  -13.1524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5831  -13.5638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7011  -13.1502    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.4098  -13.5589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1142  -13.1518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1161  -12.3342    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.4073  -11.9255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6968  -12.3343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  6  7  1  0
  4 13  1  0
 13 14  1  0
 10 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  2  0
 14 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 14  1  0
 25 26  1  0
 25 30  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 22 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4746272

    ---

Associated Targets(Human)

JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYK2 Tclin Tyrosine-protein kinase TYK2 (5029 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BLK Tchem Tyrosine-protein kinase BLK (2498 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BMX Tchem Tyrosine-protein kinase BMX (1995 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BTK Tclin Tyrosine-protein kinase BTK (8973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB4 Tclin Receptor protein-tyrosine kinase erbB-4 (2748 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITK Tclin Tyrosine-protein kinase ITK/TSK (3699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TEK Tclin Tyrosine-protein kinase TIE-2 (3348 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RET Tclin Tyrosine-protein kinase receptor RET (6732 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Jak3 Tyrosine-protein kinase JAK3 (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 401.47Molecular Weight (Monoisotopic): 401.1852AlogP: 3.85#Rotatable Bonds: 6
Polar Surface Area: 79.38Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.04CX LogP: 4.09CX LogD: 4.09
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.61Np Likeness Score: -1.47

References

1. Shu L,Chen C,Huan X,Huang H,Wang M,Zhang J,Yan Y,Liu J,Zhang T,Zhang D.  (2020)  Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors.,  191  [PMID:32097841] [10.1016/j.ejmech.2020.112148]

Source